Ishikazu Mizuno
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Lymphoid blast crisis in chronic myeloid leukemia after long-term treatment-free remission following imatinib treatment
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Journal: Cancer chemotherapy and pharmacology
Published: December 21, 2024
Reduced-intensity conditioning with fludarabine/busulfan versus fludarabine/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: April 12, 2024
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.
Journal: Annals of hematology
Published: September 06, 2022
Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up.
Journal: Journal of cancer survivorship : research and practice
Published: February 26, 2021
Expression of activated integrin β7 in multiple myeloma patients.
Journal: International journal of hematology
Published: February 22, 2021
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Journal: British journal of haematology
Published: April 15, 2020
The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse.
Journal: International journal of hematology
Published: March 09, 2020
Systemic mastocytosis with refractory ascites successfully treated with interferon-α and a leukotriene receptor antagonist
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 17, 2019
A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: October 05, 2019
Last Updated: 09/26/2026